Longitudinal FEV1 and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling

Longitudinal FEV1 and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling

Kirill Zhudenkov,1 Robert Palmér,2 Alexandra Jauhiainen,3 Gabriel Helmlinger,4,5 Oleg Stepanov,1 Kirill Peskov,1,6 Ulf G Eriksson,2 Ulrika Wählby Hamrén2 1M&S Decisions LLC, Moscow, Russia; 2Clinical Pharmacology & Quantitative Pharmacology, Clinical Ph...

Full description

Bibliographic Details
Main Authors: Zhudenkov K, Palmér R, Jauhiainen A, Helmlinger G, Stepanov O, Peskov K, Eriksson UG, Wählby Hamrén U
Format: Article
Language:English
Published: Dove Medical Press 2021-01-01
Series:International Journal of COPD
Subjects:
lung function
bronchodilator
anti-inflammatory
Online Access:https://www.dovepress.com/longitudinal-fev1-and-exacerbation-risk-in-copd-quantifying-the-associ-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/longitudinal-fev1-and-exacerbation-risk-in-copd-quantifying-the-associ-peer-reviewed-article-COPD

Similar Items